blind
random
control
multicentr
field
studi
conduct
french
dairi
farm
n
evalu
long
term
efficaci
metaphylact
singl
oral
treatment
either
mgkg
bodi
weight
bw
diclazuril
vecoxan
mgkg
bw
toltrazuril
baycox
natur
infect
eimeria
zuernii
andor
eimeria
bovi
compar
untreat
control
anim
total
calv
nine
commerci
farm
age
day
old
start
studi
includ
randomli
alloc
one
three
group
calv
farm
observ
period
day
post
treatment
use
parasitolog
oocyst
excret
clinic
paramet
faecal
score
bodi
weight
assess
efficaci
base
control
oocyst
excret
averag
daili
weight
gain
throughout
studi
whole
studi
period
mean
number
day
diarrhoea
similar
day
treat
group
excret
untreat
group
peak
day
treatment
diclazuril
toltrazuriltr
group
mean
oocyst
excret
decreas
dramat
five
day
follow
treatment
thereaft
particularli
toward
end
studi
period
oocyst
count
percentag
level
e
zuernii
highest
toltrazuriltr
group
pool
data
trial
site
averag
daili
weight
gain
significantli
p
higher
kgday
diclazuril
group
compar
toltrazuril
group
averag
bodi
weight
gain
diclazuril
treat
group
kg
higher
toltrazuril
group
eight
nine
trial
site
averag
daili
gain
greater
diclazuril
group
toltrazuril
group
studi
demonstr
extend
observ
period
day
metaphylact
treatment
diclazuril
toltrazuril
reduc
impact
coccidiosi
greater
perform
benefit
base
averag
daili
weight
gain
achiev
follow
use
diclazuril
histor
bovin
coccidiosi
consid
sever
infect
calf
wean
period
week
thereaft
week
prior
wean
rotaviru
coronaviru
escherichia
coli
pathogen
consid
common
caus
diarrhoea
consid
coccidiosi
sever
concern
calv
younger
month
age
recent
sever
survey
shown
young
calv
birth
month
old
infect
eimeria
bovi
eimeria
zuernii
pathogen
coccidia
cattl
daugshi
najdrowski
poor
hygien
overcrowd
stress
situat
transport
wean
etc
increas
risk
contract
coccidiosi
day
follow
birth
calv
infect
cryptosporidium
parvum
sometim
first
week
life
giardia
intestinali
strongyloid
papillosu
end
first
month
coccidia
preval
numer
oocyst
expel
faec
recycl
quickli
alzieu
et
al
maximum
intens
coccidiosi
occur
week
week
birth
et
al
et
al
sever
recent
paper
stress
bovin
coccidiosi
global
problem
spread
infect
equal
dairi
beef
calv
intestin
damag
common
subsequ
symptom
decreas
weight
gain
weak
secondari
bacteri
infect
frequent
report
daugshi
najdrowski
von
samsonhimmelstjerna
et
al
bangoura
daugschi
coccidiosi
gener
diagnos
faecal
examin
order
detect
oocyst
greatli
recommend
pathogen
speci
identifi
present
report
purpos
parasitologist
consid
presenc
e
zuernii
andor
e
bovi
oocyst
import
number
jolley
bardsley
strong
correl
number
oocyst
shed
sever
clinic
sign
practition
must
distinguish
viral
bacteri
parasit
agent
involv
develop
gut
diseas
young
calv
haemorrhag
diarrhoea
coccidiosi
common
mild
infect
pathogen
coccidia
e
zuernii
e
bovi
impair
nutrient
absorpt
caus
dramat
chang
villou
architectur
reduct
epitheli
cell
height
decreas
extent
brush
border
mundt
et
al
lesion
result
reduct
surfac
area
avail
absorpt
consequ
decreas
feed
effici
taylor
et
al
infect
anim
develop
effect
protect
immun
homolog
reinfect
et
al
increas
level
interferongamma
primari
infect
appear
key
featur
coccidiosi
control
taubert
et
al
econom
consequ
coccidiosi
calv
must
control
unfortun
late
interven
appear
first
clinic
sign
signific
tissu
damag
alreadi
occur
time
treatment
respect
impact
growth
therefor
critic
well
infect
anim
spread
million
oocyst
heavili
contamin
environ
spread
infect
younger
calv
anticoccidi
product
often
use
control
coccidiosi
calv
howev
drug
benzen
acetonitril
diclazuril
toltrazuril
great
efficaci
preexist
infect
pathogen
eimeria
spp
desir
scenario
would
kill
parasit
also
allow
develop
natur
immun
agneessen
et
al
taylor
et
al
sever
studi
confirm
efficaci
drug
bovin
coccidiosi
trial
use
either
diclazuril
daugshi
najdrowski
daugschi
et
al
romero
et
al
toltrazuril
bohrmann
mundt
et
al
epe
et
al
mundt
et
al
compar
mundt
et
al
veronesi
et
al
one
studi
veronesi
et
al
monitor
period
compar
short
typic
less
day
aim
present
studi
investig
effect
metaphylact
treatment
diclazuril
vecoxan
toltrazuril
baycox
bovi
natur
infect
e
zuernii
andor
e
bovi
dairi
calv
longer
day
period
august
march
nine
commerci
dairi
farm
brittani
franc
select
base
previou
histori
coccidiosi
outbreak
detail
investig
conduct
blind
random
control
field
trial
accord
good
clinic
practic
vich
guidelin
nation
anim
welfar
requir
trial
site
three
group
calv
randomli
assign
three
differ
prevent
treatment
coccidiosi
separ
pen
tabl
group
diclazuril
treat
mgkg
bodi
weight
vecoxan
suspens
elanco
anim
health
group
b
toltrazuril
treat
mgkg
bodi
weight
baycox
bovi
suspens
bayer
anim
health
group
c
untreat
control
calv
group
b
treat
close
time
expect
observ
clinic
coccidiosi
usual
week
group
anim
collect
pen
coccidiosi
endem
treatment
given
studi
day
ie
day
group
collect
pen
total
one
hundr
nineti
nine
healthi
calv
primarili
holstein
montbeliard
brittani
area
franc
randomli
select
nine
dairi
farm
calv
per
farm
twenti
two
sequenc
conduct
total
calv
includ
sequenc
divid
three
group
b
c
contain
number
treat
anim
one
untreat
calf
sentinel
control
ratio
depend
number
calv
per
farm
inclus
sequenc
calv
hous
individu
pen
two
week
treatment
move
collect
pen
studi
day
calv
treatment
group
randomli
select
accord
criteria
age
sex
bodi
weight
breed
end
studi
calv
hous
collect
pen
separ
accord
treatment
group
calv
individu
monitor
ie
end
trial
none
calv
receiv
anticoccidi
treatment
prior
begin
trial
begin
studi
diclazuril
toltrazuriltr
group
b
statist
differ
regard
age
oocyst
excret
bodi
weight
sex
faecal
score
p
tabl
calv
submit
three
complet
health
check
individu
weight
record
individu
bodi
weight
quantifi
weigh
calv
weigh
scale
calibr
use
individu
rectal
faec
sampl
taken
twice
weekli
faecal
consist
evalu
immedi
site
accord
faecal
score
fs
use
score
system
diarrhoea
normal
faec
pasti
faec
semiliquid
wateri
faec
wateri
faec
blood
wateri
faec
blood
tissu
diarrhoea
present
fs
oocyst
count
perform
use
modifi
mcmaster
method
mix
g
faec
per
ml
satur
nacl
solut
specif
graviti
faecal
oocyst
count
evalu
speci
identifi
directli
accord
size
shape
nonsporul
oocyst
taylor
et
al
pathogen
coccidia
e
bovi
e
zuernii
faecal
excret
opg
usual
accept
threshold
indic
coccidiainduc
diarrhoea
mundt
et
al
data
collect
individu
trial
site
pool
analyz
descript
statist
nonparametr
statist
test
use
perform
comparison
group
qualit
data
qualit
oocyst
excret
incid
preval
diarrhoea
test
fisher
exact
test
quantit
data
quantit
oocyst
excret
bodi
weight
age
test
mannwhitney
test
growth
perform
analyz
calcul
weight
gain
end
studi
period
day
treatment
multipl
linear
regress
model
mix
effect
use
compar
averag
daili
gain
group
effect
consid
signific
error
level
p
lower
trial
site
control
calv
expel
oocyst
faecal
examin
highest
mean
count
group
observ
fig
decreas
oocyst
differenti
sampl
taken
control
calv
indic
e
bovi
predomin
initi
period
declin
pattern
e
zuernii
oocyst
excret
follow
e
bovi
fluctuat
higher
number
percentag
presenc
throughout
studi
period
fig
oocyst
excret
nonpathogen
eimeria
speci
also
fluctuat
throughout
suggest
exposur
sever
differ
speci
time
total
oocyst
e
bovi
e
zuernii
output
two
treatment
group
also
given
fig
eimeria
speci
present
shown
fig
percentag
tabl
observ
find
treatment
group
start
trial
group
calv
excret
oocyst
two
pathogen
coccidia
speci
e
zuernii
e
bovi
opg
treatment
control
group
given
fig
although
appar
less
treat
calv
infect
number
calv
excret
oocyst
two
treat
group
dramat
decreas
five
day
follow
treatment
percentag
calv
excret
oocyst
group
b
toltrazuril
significantli
p
lower
calv
group
diclazuril
less
differ
observ
except
percentag
calv
group
diclazuril
excret
oocyst
significantli
p
lower
group
b
calv
toltrazuril
two
month
treatment
almost
toltrazuriltr
calv
shed
oocyst
pathogen
coccidia
speci
e
zuernii
e
bovi
opg
largest
proport
e
zuernii
fig
entir
studi
period
mean
number
day
diarrhoea
faecal
score
treat
group
low
similar
day
p
shown
treat
group
untreat
control
display
higher
day
day
diarrhoea
faecal
score
greater
diclazuril
toltrazuriltr
group
percentag
calv
show
diarrhoea
decreas
fig
statist
differ
treatment
group
trial
site
averag
bodi
weight
gain
group
calv
diclazuril
kg
higher
group
b
calv
toltrazuril
use
multipl
linear
regress
model
mix
effect
data
normal
distribut
shapirowilk
normal
test
pvalu
diclazuril
treat
calv
averag
daili
gain
adg
kgday
significantli
p
higher
compar
calv
toltrazuril
group
week
posttreat
observ
period
adg
significantli
differ
two
treatment
group
wherea
adg
group
diclazuril
calv
higher
gday
compar
group
b
toltrazuril
calv
fig
adg
differ
notic
trial
site
like
due
differ
breed
farm
manag
practic
fig
eight
nine
trial
site
higher
adg
record
diclazuriltr
calv
comparison
toltrazuriltr
calv
statist
analysi
signific
individu
farm
level
due
limit
number
calv
includ
trial
site
publish
studi
deal
control
bovin
coccidiosi
confirm
benzen
acetonitril
compound
effect
variou
life
cycl
stage
eimeria
consequ
well
suit
metaphylact
treatment
bohrmann
time
treatment
import
particularli
dairi
calv
typic
spend
first
week
life
individu
pen
gather
calv
infect
yard
often
differ
premis
time
calv
expos
multipl
stress
subsequ
prone
bacteri
viral
parasit
infect
well
known
coccidiosi
treatment
time
cur
retrospect
time
treatment
late
avoid
develop
extens
intestin
lesion
consequ
practition
administ
metaphylact
treatment
day
movement
calv
dairi
farm
studi
inclus
sentinel
control
calv
confirm
high
level
oocyst
excret
ie
day
introduct
onto
respect
farm
presenc
oocyst
count
opg
compris
approxim
pathogen
eimeria
speci
fig
result
fulli
justifi
time
metaphylact
treatment
one
benzen
acetonitril
anticoccidi
product
ideal
administr
drug
first
infect
allow
develop
immun
protect
new
sever
coccidia
infect
four
main
criteria
allow
comparison
trial
result
benzen
acetonitril
bohrmann
mundt
et
al
mundt
et
al
mundt
et
al
daugshi
najdrowski
epe
et
al
daugschi
et
al
veronesi
et
al
romero
et
al
durat
studi
fig
averag
daili
weight
gain
kgday
trial
site
oocyst
excret
pathogen
speci
diarrhoea
score
bodi
weight
gain
orand
adg
previou
studi
consid
goal
treatment
suppress
oocyst
excret
ie
parasitolog
criteria
evalu
directli
field
studi
clinic
criteria
diarrhoea
growth
perform
also
consid
addit
use
indic
monitor
treatment
efficaci
compar
previou
report
studi
studi
bring
result
longer
monitor
period
day
post
treatment
along
higher
number
calv
includ
trial
mean
age
calv
begin
trial
day
end
trial
day
ie
period
highest
suscept
clinic
coccidiosi
taylor
catchpol
case
previous
describ
studi
compar
toltrazuril
diclazuril
one
studi
give
short
followup
period
day
mundt
et
al
studi
veronesi
et
al
two
group
calv
treat
drug
nontreat
control
group
monitor
period
week
data
provid
kinet
oocyst
excret
result
trial
therefor
easili
compar
shorter
durat
trial
due
fact
calv
reportedli
typic
suscept
clinic
coccidiosi
week
six
month
field
taylor
catchpol
fact
difficult
attribut
effect
singl
metaphylact
treatment
week
later
kinet
compar
studi
mundt
et
al
trial
differ
respect
studi
period
studi
oocyst
disappear
faec
five
day
posttreat
reappear
rapidli
group
diclazuril
calv
compar
group
b
toltrazuril
calv
howev
second
part
studi
level
oocyst
excret
group
b
toltrazuril
calv
increas
compar
group
diclazuril
treat
calv
initi
challeng
period
predomin
pathogen
speci
present
e
bovi
declin
supersed
e
zuernii
level
nonpathogen
eimeria
speci
fluctuat
throughout
toward
end
studi
period
howev
oocyst
count
percentag
pathogen
speci
opg
opg
higher
toltrazuriltr
group
e
zuernii
predomin
summaris
higher
level
protect
provid
immedi
posttreat
prevent
develop
speciesspecif
immun
e
zuernii
toltrazuriltr
group
lead
subclin
coccidiosi
impact
growth
due
publish
persist
toltrazuril
observ
highli
unlik
observ
previous
publish
trial
shorter
durat
farmer
use
treat
calv
soon
diarrhoea
observ
group
young
calv
similar
studi
daugshi
najdrowski
mundt
et
al
signific
correl
shown
diarrhoea
oocyst
excret
trial
present
studi
report
mean
durat
diarrhoea
day
treatment
result
similar
report
mundt
et
al
trial
group
without
show
signific
differ
criterion
one
critic
clinic
perspect
allow
object
evalu
clinic
criteria
consequ
metaphylact
treatment
studi
diclazuriltr
group
group
mean
bodi
weight
kg
greater
toltrazuriltr
group
group
b
unlik
find
mundt
et
al
demonstr
adg
significantli
higher
kgday
p
diclazuriltr
group
group
compar
toltrazuriltr
group
group
b
find
probabl
result
longer
studi
period
main
effect
metaphylact
treatment
observ
one
month
administr
import
factor
farmer
higher
growth
rate
must
stress
result
observ
within
period
report
highest
suscept
calv
coccidiosi
week
month
age
rear
commerci
farm
condit
interestingli
possibl
differenti
two
period
studi
despit
higher
percentag
calv
excret
oocyst
diclazuriltr
group
calv
adg
faecal
score
similar
two
group
b
percentag
calv
excret
oocyst
increas
toltrazuriltr
group
b
adg
higher
diclazuriltr
group
calv
toltrazuriltr
group
b
calv
latter
period
compris
total
differ
adg
group
may
appear
surpris
particular
regard
concept
metaphylact
treatment
control
coccidiosi
older
calv
suppress
oocyst
excret
longer
period
time
toltrazuriltr
calv
correl
higher
growth
perform
lower
diarrhoea
epidemiolog
studi
et
al
et
al
alzieu
et
al
show
younger
calv
suscept
coccidiosi
peak
averag
excret
preval
day
age
neonat
calv
immunolog
birth
develop
immun
system
calv
progress
concept
matur
approxim
month
birth
order
enhanc
adapt
immun
respons
newborn
calv
need
experi
pathogen
chase
et
al
consequ
persist
longeract
treatment
coccidiosi
young
calv
could
delay
develop
immun
respons
respect
toltrazuriltr
calv
studi
display
peak
excret
preval
day
treatment
suggest
detriment
effect
growth
perform
previous
surmis
treatment
benzen
acetonitril
compound
may
effect
develop
immun
coccidi
infect
cattl
treatment
interfer
acquisit
immun
follow
subsequ
reexposur
sever
diseas
may
follow
jonsson
et
al
studi
conduct
taylor
et
al
diclazuril
given
mgkg
bw
recommend
dose
lamb
demonstr
dose
level
treatment
effect
prevent
coccidiosi
lamb
higher
dose
level
mgkg
bw
appear
complet
clear
lamb
coccidia
render
suscept
reinfect
due
differ
pharmacokinet
properti
diclazuril
toltrazuril
hypothes
differ
dose
rate
diclazuril
mgkg
toltrazuril
mgkg
subsequ
period
activ
could
explain
toltrazuriltr
calv
appear
suscept
infect
day
post
treatment
compar
diclazuriltr
calv
demonstr
differ
growth
perform
increas
level
oocyst
excret
studi
confirm
benzen
acetonitril
drug
effect
control
pathogen
coccidia
e
bovi
e
zuernii
choic
correct
time
begin
prevent
treatment
must
care
determin
base
histori
farm
manag
calv
case
coccidiosi
typic
develop
day
stress
event
movement
farm
oocyst
count
insuffici
evalu
efficaci
metaphylact
treatment
speciat
also
undertaken
studi
monitor
adg
longer
posttreat
period
identifi
advantag
effect
metaphylat
treatment
dairi
calv
diclazuril
shorter
durat
action
appear
allow
better
degre
exposur
suffici
number
speci
eimeria
subsequ
speciesspecif
protect
immun
develop
studi
report
herein
fund
elanco
anim
health
neuilli
sur
sein
franc
except
dr
philipp
paid
employe
elanco
anim
health
remain
author
conflict
interest
may
bias
work
involv
studi
design
studi
conduct
data
analysi
review
manuscript
